PART I ITEM 1 - BUSINESS Overview Impact Biomedical Inc. (IBO. Impact, Impact BioMedical, we, us, our or the Company) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships, and currently trades on the NYSE American under ticker symbol IBO. By leveraging technology and new science with strategic par...
Q2 FY2026 — expected 2026-07-22
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-11 | 2025-12-31 | 0001493152-26-009711 | EDGAR | 42K words |
| 2025-03-28 | 2024-12-31 | 0001641172-25-001199 | EDGAR | — |
| 2024-02-20 | 2023-12-31 | 0001493152-24-007229 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001493152-26-036601 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001493152-25-021286 | EDGAR | 19K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-023809 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010276 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044792 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031635 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001493152-24-018663 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040547 | EDGAR | — |
| 2023-10-05 | 2023-06-30 | 0001493152-23-036365 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-04 | 0001493152-26-008879 | EDGAR | 1K words |
| 2025-11-06 | 0001493152-25-021066 | EDGAR | — |
| 2025-10-27 | 0001493152-25-019734 | EDGAR | — |
| 2025-07-28 | 0001641172-25-021085 | EDGAR | — |
| 2025-06-23 | 0001641172-25-016002 | EDGAR | — |
| 2025-04-03 | 0001641172-25-002577 | EDGAR | — |
| 2025-03-28 | 0001641172-25-001060 | EDGAR | — |
| 2025-03-13 | 0001493152-25-010190 | EDGAR | — |
| 2025-01-29 | 0001493152-25-004161 | EDGAR | — |
| 2024-11-04 | 0001493152-24-043558 | EDGAR | — |
51 total filings indexed. 29 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001834105 |
| Ticker | IBO |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.impactbiomedinc.com |
| Listed | 2024-09-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IBO (~200 tokens, structured JSON with cryptographic provenance)